EGFRvIII-targeted CAR-T immunotherapy 
Welcome,         Profile    Billing    Logout  
  Companies   Products    Products    Diseases    Trials    News 

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Products
 012345678910
            
                                                                                                      
            
Gilead           
          
            
Massachusetts General Hospital           
          
            
National Cancer Institute           
          
            
Novartis           
          
            
Shanghai Simnova Bio           
          
            
Shenzhen BinDeBio           
          
            
Suzhou Maximum Bio-tech           
          
            
University of Pennsylvania